Zacks Investment Research upgraded shares of MERIT MEDICAL (MMSI) from UNDERPERFORM to NEUTRAL on April 24, 2013, with a target price of $11.60.
Merit Medical Systems, Inc. was formed for the purpose of producing single-use medical products of high quality and superior value primarily for use in diagnosis and treatment of cardiovascular disease. The company's products are designed to provide physicians and other health care professionals with devices that enable them to perform interventional and diagnostic procedures safely and effectively.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
To get a free copy of the research report on MERIT MEDICAL (MMSI),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .
Be the first to comment